Implementation and Evaluation of the Pathway Platform: A Digitally Enabled Care Pathway to Improve Depression Management in Primary Care

Presenter/Author Information

Ramona Donovan MS, Advocate Aurora Research Institute, Advocate HealthFollow
Rasha Khatib PhD, MHS, Advocate Aurora Research Institute, Advocate HealthFollow
Christopher Blair MS, Takeda Pharmaceuticals U.S.A, Inc
Maggie McCue, Takeda Pharmaceuticals U.S.A, Inc
Ben Fehnert Cognition Kit, Cambridge, UK and Ctrl Group, Fora Health, London, UK
James King, Ctrl Group/Fora Health, London, UK
Michael Martin, Takeda Pharmaceuticals U.S.A., Inc
Marybeth Ingle PhD, MPH, Advocate Aurora Research Institute, Advocate HealthFollow
Iridian Guzman MPH, Advocate Aurora Research Institute, Advocate HealthFollow
David Kemp MD, Behavioral Health, Advocate Christ Medical Center, Advocate HealthFollow

Recommended Citation

Donovan R, Khatib R, Blair C, et al. Implementation and Evaluation of the Pathway Platform: A Digitally Enabled Care Pathway to Improve Depression Management in Primary Care. Presented at Scientific Day; May 22, 2024; Milwaukee, WI.

Affiliations

Advocate Aurora Research Institute, Advocate Christ Medical Center

Presentation Notes

Presented at Scientific Day; May 22, 2024; Milwaukee, WI.
2nd place Oral Presentation Award recipient.

Document Type

Oral/Podium Presentation